Kangji Medical Holdings Future Growth

Future criteria checks 2/6

Kangji Medical Holdings is forecast to grow earnings and revenue by 14.3% and 15.9% per annum respectively while EPS is expected to grow by 14.3% per annum.

Key information

14.3%

Earnings growth rate

14.3%

EPS growth rate

Medical Equipment earnings growth	15.9%
Revenue growth rate	15.9%
Future return on equity	n/a
Analyst coverage	Low
Last updated	21 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:50J - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	1,468	772	N/A	N/A	1
12/31/2025	1,239	651	N/A	N/A	2
12/31/2024	1,067	575	N/A	N/A	2
6/30/2024	981	534	373	472	N/A
3/31/2024	953	519	353	446	N/A
12/31/2023	926	504	333	420	N/A
9/30/2023	892	540	312	390	N/A
6/30/2023	858	576	291	360	N/A
3/31/2023	822	528	267	340	N/A
12/31/2022	786	479	242	319	N/A
9/30/2022	745	447	261	326	N/A
6/30/2022	704	415	281	332	N/A
3/31/2022	697	436	343	384	N/A
12/31/2021	690	457	405	436	N/A
9/30/2021	654	413	379	405	N/A
6/30/2021	617	369	353	374	N/A
3/31/2021	564	310	278	298	N/A
12/31/2020	511	250	203	221	N/A
9/30/2020	506	227	246	261	N/A
6/30/2020	500	204	290	301	N/A
3/31/2020	502	205	303	313	N/A
12/31/2019	503	206	316	326	N/A
12/31/2018	354	147	189	205	N/A
12/31/2017	248	118	N/A	143	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 50J's forecast earnings growth (14.3% per year) is above the savings rate (0.8%).

Earnings vs Market: 50J's earnings (14.3% per year) are forecast to grow slower than the German market (20% per year).

High Growth Earnings: 50J's earnings are forecast to grow, but not significantly.

Revenue vs Market: 50J's revenue (15.9% per year) is forecast to grow faster than the German market (5.4% per year).

High Growth Revenue: 50J's revenue (15.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 50J's Return on Equity is forecast to be high in 3 years time

Kangji Medical Holdings Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Recent updates

First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023)

First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023)

Kangji Medical Holdings Limited to Report First Half, 2024 Results on Aug 20, 2024

New minor risk - Share price stability

Kangji Medical Holdings Limited Approves Special Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024

Upcoming dividend of CN¥1.40 per share

Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.40 in FY 2022)

Kangji Medical Holdings Limited Proposes Special Dividend for the Year Ended December 31, 2023

New major risk - Dividend sustainability

Dividend of CN¥1.40 announced

Kangji Medical Holdings Limited, Annual General Meeting, May 27, 2024

New minor risk - Share price stability

Kangji Medical Holdings Limited Announces CFO Changes

First half 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1H 2022)

Kangji Medical Holdings Limited to Report First Half, 2023 Results on Aug 29, 2023

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Kangji Medical Holdings Limited Approves Payment of Final Dividend for the Year Ended December 31, 2022, Payment Date Is 10 July 2023

Full year 2022 earnings released

Less than half of directors are independent

First half 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.16 in 1H 2021)

Kangji Medical Holdings Limited to Report First Half, 2022 Results on Aug 25, 2022

Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021, Payment date is 08 July 2022

Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021

Upcoming dividend of HK$0.17 per share

Kangji Medical Holdings Limited Announces Executive Changes

Full year 2021 earnings released: EPS: CN¥0.37 (vs CN¥0.26 in FY 2020)

Less than half of directors are independent

Kangji Medical Holdings Limited to Report Fiscal Year 2021 Results on Mar 22, 2022

Investor sentiment improved over the past week

First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.12 in 1H 2020)

Investor sentiment improved over the past week

Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2020

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.26 (vs CN¥0.31 in FY 2019)

Kangji Medical Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2020

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.26 (vs CN¥0.31 in FY 2019)

Kangji Medical Holdings Limited to Report Fiscal Year 2020 Results on Mar 25, 2021

Investor sentiment deteriorated over the past week

New 90-day low: €1.15

New 90-day low: €1.27

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day low: €1.50

Market pulls back on stock over the past week

New 90-day low: €2.06

Kangji Medical Holdings Limited Appoints Frances Fang Chovanec as Executive Director

First half earnings released

Earnings released

Kangji Medical Holdings Limited to Report First Half, 2020 Results on Aug 25, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies